Mylotarg and white blood cell count decreased Patient Reports February 12, 2012

Mylotarg Side Effects Report #5226095-3
Mylotarg side effect was reported by a Physician from JAPAN on Jan 23, 2007. Male patient, weighting 163.1 lb, was diagnosed with t-cell type acute leukaemia, prophylaxis and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: neutropenia, performance status decreased, pleurisy, pneumonia

, venoocclusive liver disease, white blood cell count decreased. Mylotarg dosage: unknown. During the same period patient was treated with BACTRIM, ACINON, ASPARTATE CALCIUM, VITAJECT, ALFAROL, FRAGMIN. Patient was hospitalized. Patient died on 08/24/2006.

Mylotarg Side Effects Report #5344325-4
Mylotarg side effect was reported by a Physician from JAPAN on May 25, 2007. Male patient, weighting 163.1 lb, was diagnosed with t-cell type acute leukaemia, prophylaxis and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: multi-organ failure, neutropenia, performance status decreased, pleurisy, pneumonia

, venoocclusive liver disease, white blood cell count decreased. Mylotarg dosage: unknown. During the same period patient was treated with BAKTAR, ACINON, ASPARTATE CALCIUM, VITAJECT, ALFAROL, FRAGMIN. Patient was hospitalized. Patient died on 08/24/2006.

Mylotarg Side Effects Report #4673564-0
Mylotarg side effect was reported by a Consumer or non-health professional from on May 09, 2005. Female patient, 81 years of age, weighting 204.7 lb, was diagnosed with myelodysplastic syndrome and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: blood pressure systolic increased, febrile neutropenia, lung neoplasm, platelet count decreased, scar

, splenomegaly, white blood cell count decreased. Mylotarg dosage: 15 MG 1X PER 1 DAY, INTRAVENOUS. Patient was hospitalized. Patient recovered.

Mylotarg Side Effects Report #4867534-7
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Dec 13, 2005. Male patient, 76 years of age, weighting 175.0 lb, was diagnosed with myelodysplastic syndrome and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: febrile neutropenia, white blood cell count decreased. Mylotarg dosage: A SINGLE 6 MG DOSE, INTRAVENOUS. During the same period patient was treated with ARSENIC TRIOXIDE, ATENOLOL, SYNTHROID, PRILOSEC, PROSCAR, VITAMINS, LOTREL, FLOMAX. Patient was hospitalized. Patient recovered.

Mylotarg Side Effects Report #4977595-2
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Apr 04, 2006. Male patient, 76 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: anaemia, c-reactive protein increased, febrile neutropenia, neutrophil count decreased, platelet count decreased, white blood cell count decreased. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY INTRAVENOUS DRIP. During the same period patient was treated with SULFAMETHOXAZOLE, CIPROFLOXACIN HYDROCHLORIDE, FLUCONAZOLE, ROXATIDINE ACETATE. Patient recovered.

Mylotarg Side Effects Report #5217521-4
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Jan 11, 2007. Male patient, 71 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: abdominal pain upper, c-reactive protein increased, disseminated intravascular coagulation, febrile neutropenia, haematocrit decreased, haemoglobin decreased, peptic ulcer

, white blood cell count decreased. Mylotarg dosage: 6 MG/M^2 1X PER DAY INTRAVENOUS DRIP. During the same period patient was treated with ZANTAC, MUCOSTA, DIFLUCAN, POLYMYXIN B SULPHATE, CLARITHROMYCIN, SULFAMETHOXAZOLE. Patient was hospitalized. Patient recovered.

Mylotarg Side Effects Report #5074397-6
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on July 24, 2006. Female patient, 70 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: enterocolitis, neutrophil count decreased, platelet count decreased, pneumonia staphylococcal, sepsis

, systemic candida, white blood cell count decreased. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY, INTRAVENOUS DRIP. Patient was hospitalized. Patient recovered.

Mylotarg Side Effects Report #5087410-7
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Aug 09, 2006. Female patient, 64 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: hepatic function abnormal, infusion related reaction, laryngeal oedema, neutropenia, sinusitis aspergillus, thrombocytopenia, white blood cell count decreased. Mylotarg dosage: 9 MG/M^2 PER 1 DAY INTRAVENOUS DRIP. During the same period patient was treated with MAXIPIME, FUNGUARD, STRONG NEO MINOPHAGEN C, SULFAMETHOXAZOLE, MUCOSTA, NORVASC, AMOBAN. Patient was hospitalized. Patient recovered.

Mylotarg Side Effects Report #5145343-1
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Oct 24, 2006. Female patient, 64 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: febrile neutropenia, hepatic function abnormal, infusion related reaction, laryngeal oedema, sinusitis aspergillus, thrombocytopenia, white blood cell count decreased. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY INTRAVENOUS DRIP; SEE IMAGE. During the same period patient was treated with MAXIPIME, FUNGUARD, SULFAMETHOXAZOLE, MUCOSTA, NORVASC, AMOBAN, VFEND. Patient was hospitalized. Patient recovered.

Mylotarg Side Effects Report #5148290-4
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Nov 01, 2006. Female patient, 64 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: body temperature decreased, febrile neutropenia, hepatic function abnormal, infusion related reaction, laryngeal oedema, sinusitis aspergillus, thrombocytopenia, white blood cell count decreased. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY INTRAVENOUS DRIP; SEE IMAGE. During the same period patient was treated with MAXIPIME, FUNGUARD, SULFAMETHOXAZOLE, MUCOSTA, NORVASC, AMOBAN, VFEND. Patient was hospitalized. Patient recovered.

Mylotarg Side Effects Report #5223781-6
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Jan 18, 2007. Male patient, 61 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, bronchopulmonary aspergillosis, cardio-respiratory arrest, hepatic function abnormal, white blood cell count decreased. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY INTRAVENOUS DRIP. During the same period patient was treated with ITRACONAZOLE, LEVOFLOXACIN, FAMOTIDINE, BACTRIM. Patient died.

Mylotarg Side Effects Report #5150443-6
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Oct 31, 2006. Male patient, 61 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: aspartate aminotransferase decreased, bronchopulmonary aspergillosis, hepatic function abnormal, white blood cell count decreased. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY, INTRAVENOUS DRIP. During the same period patient was treated with ITRACONAZOLE, LEVOFLOXACIN, FAMOTIDINE, BACTRAMIN. Patient died.

Mylotarg Side Effects Report #5113465-7
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Sept 08, 2006. Male patient, 59 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: anaemia, central line infection, fibrin degradation products increased, sepsis

, venoocclusive liver disease, white blood cell count decreased. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY. During the same period patient was treated with ENOCITABINE, ETOPOSIDE, NOVANTRONE, LEVOFLOXACIN, ITRACONAZOLE, ALLOPURINOL, FAMOTIDINE, SUCRALFATE. Patient was hospitalized. Patient recovered.

Mylotarg Side Effects Report #5025813-7
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on May 31, 2006. Male patient, 59 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: anaemia, blood albumin increased, central line infection, fibrin degradation products increased, hepatic function abnormal, sepsis

, venoocclusive liver disease, white blood cell count decreased. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY INTRAVENOUS DRIP. During the same period patient was treated with LEVOFLOXACIN, ITRACONAZOLE, ALLOPURINOL, FAMOTIDINE, SUCRALFATE, BIOFERMIN R, URSO, BICARBONATE. Patient was hospitalized. Patient recovered.

Mylotarg Side Effects Report #5132919-0
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Oct 04, 2006. Male patient, 58 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: anaemia, liver disorder, pharyngitis, platelet count decreased, pneumonia

, septic shock, white blood cell count decreased. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY INTRAVENOUS DRIP. During the same period patient was treated with MAXIPIME, VANCOMYCIN, FUNGUARD, TIENAM, ITRACONAZOLE, OMEGACIN, SULFAMETHOXAZOLE. Patient was hospitalized. Patient recovered.

Mylotarg Side Effects Report #5023801-8
Mylotarg side effect was reported by a Health Professional from JAPAN on May 23, 2006. Male patient, 52 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: cardiac failure congestive, condition aggravated, disease progression, infusion related reaction, neutrophil percentage decreased, pneumonia

, white blood cell count decreased. Mylotarg dosage: A SINGLE 5 MG/M^2 DOSE INTRAVENOUS DRIP. During the same period patient was treated with BICARBONATE, HABEKACIN, LAMIVUDINE, FAMOTIDINE, MUCOSTA, SULFAMETHOXAZOLE, POLYMYXIN, FUNGIZONE. Patient died.

Mylotarg Side Effects Report #5170515-X
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Nov 27, 2006. Female patient, 50 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: bronchopulmonary aspergillosis, depressed level of consciousness, disease progression, hyperammonaemia, pyrexia, white blood cell count decreased. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY; INTRAVENOUS DRIP; 9 MG/M^2 1X PER 1 DAY; INTRAVENOUS DRIP. During the same period patient was treated with FUNGUARD, GALENIC, CLINDAMYCIN PHOSPHATE, CEFEPIME, MINOCYCLINE, VORICONAZOLE, ISEPAMICIN SULPHATE. Patient was hospitalized. Patient recovered.

Mylotarg Side Effects Report #5110875-9
Mylotarg side effect was reported by a Health Professional from JAPAN on Sept 11, 2006. Male patient, 45 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: pneumonia

, venoocclusive liver disease, weight increased, white blood cell count decreased. Mylotarg dosage: 9MG/M^2 1X PER 1 DAY; INTRAVENOUS DRIP. During the same period patient was treated with VANCOCIN, FUNGUARD, LASIX, VFEND. Patient died.

Mylotarg Side Effects Report #5237206-8
Mylotarg side effect was reported by a Physician from JAPAN on Feb 05, 2007. Female patient, weighting 125.7 lb, was diagnosed with acute myeloid leukaemia recurrent, prophylaxis, sepsis

, hypertension, diabetes mellitus and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: malaise, neutrophil count decreased, platelet count decreased, sepsis

, systemic candida, white blood cell count decreased. Mylotarg dosage: unknown. During the same period patient was treated with ITRIZOLE, EXACIN, DIOVAN, INSULIN, FILGRASTIM. Patient was hospitalized. Patient recovered.

Mylotarg Side Effects Report #5238057-0
Mylotarg side effect was reported by a Physician from JAPAN on Feb 05, 2007. Female patient, weighting 114.6 lb, was diagnosed with acute myeloid leukaemia recurrent, sinusitis aspergillus, prophylaxis, hypertension, insomnia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: infusion related reaction, laryngeal oedema, neutropenia, sinusitis aspergillus, white blood cell count decreased. Mylotarg dosage: unknown. During the same period patient was treated with FUNGUARD, VFEND, MUCOSTA, NORVASC, AMOBAN, MAXIPIME. Patient was hospitalized. Patient recovered.

Mylotarg Side Effects Report #5238583-4
Mylotarg side effect was reported by a Physician from JAPAN on Feb 06, 2007. Male patient, weighting 138.9 lb, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: anaemia, condition aggravated, neutropenia, perianal abscess, platelet count decreased, white blood cell count decreased. Mylotarg dosage: unknown. During the same period patient was treated with KEITEN, FUNGUARD, MEROPEN, ZOVIRAX, FUNGIZONE, VANCOMYCIN HYDROCHLORIDE, TARGOCID. Patient was hospitalized. Patient recovered.

Mylotarg Side Effects Report #5257029-3
Mylotarg side effect was reported by a Physician from JAPAN on Feb 26, 2007. Female patient, weighting 123.5 lb, was diagnosed with acute myeloid leukaemia recurrent, diarrhoea, infection

, insomnia, gastritis and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: anaemia, c-reactive protein increased, febrile neutropenia, neutrophil count decreased, platelet count decreased, systemic mycosis, white blood cell count decreased. Mylotarg dosage: unknown. During the same period patient was treated with BIFIDOBACTERIUM BIFIDUM, TOBRACIN, NITRAZEPAM, TIENAM, TAKEPRON, OLOPATADINE HYDROCHLORIDE. Patient was hospitalized. Patient recovered.

Mylotarg Side Effects Report #5268144-2
Mylotarg side effect was reported by a Physician from JAPAN on Mar 08, 2007. Female patient, weighting 130.1 lb, was diagnosed with acute myeloid leukaemia recurrent, prophylaxis and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: anaemia, lung injury, mouth haemorrhage, platelet count decreased, pseudomonal sepsis, venoocclusive liver disease, white blood cell count decreased. Mylotarg dosage: unknown. During the same period patient was treated with HYDREA, SULPERAZON, HEPARIN, FUNGUARD, ZOVIRAX, DAUNORUBICIN HYDROCHLORIDE, TOBRACIN. Patient was hospitalized. Patient recovered.

Mylotarg Side Effects Report #5269629-5
Mylotarg side effect was reported by a Physician from JAPAN on Mar 09, 2007. Male patient, weighting 147.7 lb, was diagnosed with acute myeloid leukaemia recurrent, prophylaxis and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, anaemia, febrile neutropenia, haemorrhage, hepatic function abnormal, platelet count decreased, white blood cell count decreased. Mylotarg dosage: unknown. During the same period patient was treated with BAKTAR, GASTER, LENOGRASTIM, MEPTIN, LEVOFLOXACIN, DIFLUCAN, AZELASTINE. Patient was hospitalized. Patient recovered.

Mylotarg Side Effects Report #5281844-3
Mylotarg side effect was reported by a Physician from JAPAN on Mar 23, 2007. Male patient, weighting 138.9 lb, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: anaemia, condition aggravated, neutropenia, perianal abscess, platelet count decreased, white blood cell count decreased. Mylotarg dosage: unknown. During the same period patient was treated with KEITEN, FUNGUARD, MEROPEN, ZOVIRAX, FUNGIZONE, VANCOMYCIN, TARGOCID. Patient was hospitalized. Patient recovered.

Mylotarg Side Effects Report #5306874-4
Mylotarg side effect was reported by a Physician from JAPAN on Apr 13, 2007. Male patient, weighting 123.5 lb, was diagnosed with acute myeloid leukaemia recurrent, prophylaxis and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: anaemia, febrile neutropenia, neutrophil count decreased, platelet count decreased, pneumonia

, white blood cell count decreased. Mylotarg dosage: unknown. During the same period patient was treated with LIPOVAS, ENOCITABINE, FLUCONAZOLE, DAUNORUBICIN HYDROCHLORIDE, FAMOTIDINE, MICARDIS. Patient died on 10/03/2006.

Mylotarg Side Effects Report #5326593-8
Mylotarg side effect was reported by a Physician from JAPAN on May 09, 2007. Male patient, weighting 147.7 lb, was diagnosed with acute myeloid leukaemia recurrent, prophylaxis and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, anaemia, febrile neutropenia, gastrointestinal haemorrhage, hepatic function abnormal, platelet count decreased, white blood cell count decreased. Mylotarg dosage: unknown. During the same period patient was treated with BAKTAR, GASTER, LENOGRASTIM, MEPTIN, LEVOFLOXACIN. Patient was hospitalized. Patient recovered.

Mylotarg Side Effects Report #5333891-0
Mylotarg side effect was reported by a Physician from JAPAN on May 22, 2007. Female patient, weighting 123.5 lb, was diagnosed with acute myeloid leukaemia recurrent, prophylaxis, infection

, white blood cell count decreased. Mylotarg dosage: unknown. During the same period patient was treated with GLEEVEC, FLUCONAZOLE, ALTAT, BAKTAR, CIPROFLOXACIN. Patient died on 02/02/2006.

Mylotarg Side Effects Report #5357047-0
Mylotarg side effect was reported by a Physician from JAPAN on June 06, 2007. Male patient, weighting 147.7 lb, was diagnosed with acute myeloid leukaemia recurrent, prophylaxis and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, anaemia, febrile neutropenia, gastrointestinal haemorrhage, hepatic function abnormal, platelet count decreased, white blood cell count decreased. Mylotarg dosage: unknown. During the same period patient was treated with BAKTAR, GASTER, LENOGRASTIM, MEPTIN, LEVOFLOXACIN, DIFLUCAN. Patient was hospitalized. Patient recovered.

Mylotarg Side Effects Report #5376303-3
Mylotarg side effect was reported by a Physician from JAPAN on June 21, 2007. Male patient, weighting 123.5 lb, was diagnosed with acute myeloid leukaemia recurrent, prophylaxis and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: anaemia, neutrophil count decreased, platelet count decreased, pneumonia

, white blood cell count decreased. Mylotarg dosage: unknown. During the same period patient was treated with GLEEVEC, FLUCONAZOLE, ALTAT, BAKTAR, CIPROFLOXACIN. Patient was hospitalized. Patient recovered.

Mylotarg Side Effects Report #5389699-3
Mylotarg side effect was reported by a Physician from JAPAN on July 10, 2007. Female patient, weighting 123.5 lb, was diagnosed with acute myeloid leukaemia recurrent, prophylaxis, infection

, insomnia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: anaemia, c-reactive protein increased, febrile neutropenia, neutrophil count decreased, platelet count decreased, systemic mycosis, white blood cell count decreased. Mylotarg dosage: unknown. During the same period patient was treated with BIFIDOBACTERIUM BIFIDUM, TOBRACIN, NITRAZEPAM, TIENAM, LANSOPRAZOLE, OLOPATADINE HYDROCHLORIDE. Patient was hospitalized. Patient recovered.

Mylotarg Side Effects Report #5475404-9
Mylotarg side effect was reported by a Physician from JAPAN on Sept 26, 2007. Female patient, weighting 125.7 lb, was diagnosed with acute myeloid leukaemia recurrent, prophylaxis and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: blood fibrinogen decreased, condition aggravated, disseminated intravascular coagulation, fibrin degradation products increased, hypokalaemia, platelet count decreased, white blood cell count decreased. Mylotarg dosage: unknown. During the same period patient was treated with RENIVACE, ADALAT, METHYCOBAL, POTASSIUM CHLORIDE, MUCOSOLVAN, LEVOFLOXACIN, DIFLUCAN. Patient recovered.

Mylotarg Side Effects Report #5507775-9
Mylotarg side effect was reported by a Physician from JAPAN on Oct 30, 2007. Female patient, weighting 108.0 lb, was diagnosed with acute myeloid leukaemia recurrent, prophylaxis and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: blood lactate dehydrogenase increased, blood potassium decreased, fibrin degradation products increased, neutrophil count decreased, pneumonia

, sepsis

, white blood cell count decreased. Mylotarg dosage: unknown. During the same period patient was treated with LIPOVAS, ENOCITABINE, FLUCONAZOLE, DAUNORUBICIN, FAMOTIDINE, MICARDIS. Patient died on 10/03/2006.

Mylotarg Side Effects Report #5522454-X
Mylotarg side effect was reported by a Physician from JAPAN on Nov 15, 2007. Male patient, weighting 143.3 lb, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: blood bilirubin increased, neutrophil count decreased, sepsis

, white blood cell count decreased. Mylotarg dosage: unknown. During the same period patient was treated with AMIKACIN, CIPROFLOXACIN, ZYVOX, AZACTAM. Patient died on 11/10/2006.

Mylotarg Side Effects Report #5570836-2
Mylotarg side effect was reported by a Physician from JAPAN on Dec 18, 2007. Male patient, weighting 136.7 lb, was diagnosed with acute myeloid leukaemia recurrent, prophylaxis and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: platelet count decreased, pneumonia fungal, white blood cell count decreased. Mylotarg dosage: unknown. During the same period patient was treated with VFEND, CIPROFLOXACIN, HEPARIN, MUCOSTA, GASTER, SOLITA T. Patient was hospitalized. Patient recovered.

Mylotarg Side Effects Report #5601602-7
Mylotarg side effect was reported by a Physician from JAPAN on Jan 15, 2008. Female patient, weighting 125.7 lb, was diagnosed with acute myeloid leukaemia recurrent, prophylaxis and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: anaemia, condition aggravated, disseminated intravascular coagulation, hypokalaemia, platelet count decreased, white blood cell count decreased. Mylotarg dosage: unknown. During the same period patient was treated with ENALAPRIL MALEATE, ADALAT, CYANOCOBALAMIN, POTASSIUM CHLORIDE, MUCOSOLVAN, CRAVIT, DIFLUCAN. Patient recovered.

Mylotarg Side Effects Report #5649066-1
Mylotarg side effect was reported by a Physician from JAPAN on Feb 26, 2008. Female patient, weighting 125.7 lb, was diagnosed with acute myeloid leukaemia recurrent, prophylaxis and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: anaemia, bacteraemia, febrile neutropenia, venoocclusive liver disease, white blood cell count decreased. Mylotarg dosage: unknown. During the same period patient was treated with CIPROFLOXACIN, DIFLUCAN, FLUVOXAMINE MALEATE, DEPAS, ZANTAC, AMOBAN, MAGNESIUM OXIDE, GLYSENNID. Patient was hospitalized. Patient recovered.

Mylotarg Side Effects Report #5660038-3
Mylotarg side effect was reported by a Physician from JAPAN on Feb 29, 2008. Male patient, weighting 165.3 lb, was diagnosed with acute myeloid leukaemia recurrent, prophylaxis and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: cardiac failure congestive, neutrophil count decreased, platelet count decreased, pneumonia

, white blood cell count decreased. Mylotarg dosage: unknown. During the same period patient was treated with FAMOTIDINE, PREDONINE, CRAVIT, ENDOXAN, BAKTAR, FLUCONAZOLE. Patient was hospitalized. Patient recovered.

Mylotarg Side Effects Report #5713144-9
Mylotarg side effect was reported by a Physician from JAPAN on Apr 11, 2008. Female patient, weighting 74.96 lb, was diagnosed with acute myeloid leukaemia recurrent, prophylaxis, constipation

and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: haematocrit decreased, haemoglobin decreased, lymphocyte count increased, neutrophil count decreased, red blood cell count decreased, white blood cell count decreased. Mylotarg dosage: unknown. During the same period patient was treated with MINOCYCLINE HYDROCHLORIDE, MINOCYCLINE HYDROCHLORIDE, FUNGUARD, MAXIPIME, MAGNESIUM OXIDE, URSO. Patient recovered.

Mylotarg Side Effects Report #5725096-6
Mylotarg side effect was reported by a Physician from JAPAN on Apr 23, 2008. Female patient, weighting 125.7 lb, was diagnosed with acute myeloid leukaemia recurrent, prophylaxis and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: anaemia, bacteraemia, febrile neutropenia, venoocclusive liver disease, white blood cell count decreased. Mylotarg dosage: unknown. During the same period patient was treated with CIPROFLOXACIN, DIFLUCAN, FLUVOXAMINE MALEATE, DEPAS, ZANTAC, AMOBAN, MAGNESIUM OXIDE. Patient was hospitalized. Patient recovered.

Mylotarg Side Effects Report #5765767-9
Mylotarg side effect was reported by a Physician from JAPAN on May 30, 2008. Female patient, weighting 125.7 lb, was diagnosed with acute myeloid leukaemia recurrent, constipation

, prophylaxis and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, decreased appetite, fungaemia, neutrophil count decreased, platelet count decreased, pyrexia, sepsis

, white blood cell count decreased. Mylotarg dosage: unknown. During the same period patient was treated with MAGNESIUM OXIDE HEAVY, OMEPRAL, PANTOSIN, SULFAMETHOXAZOLE AND TRIMETHOPRIM, DIFLUCAN. Patient recovered.

Mylotarg Side Effects Report #5792069-7
Mylotarg side effect was reported by a Physician from JAPAN on June 19, 2008. Male patient, weighting 165.3 lb, was diagnosed with acute myeloid leukaemia recurrent, prophylaxis and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: cardiac failure congestive, neutrophil count decreased, platelet count decreased, pneumonia

, white blood cell count decreased. Mylotarg dosage: unknown. During the same period patient was treated with FAMOTIDINE, FLUCONAZOLE, LEVOFLOXACIN, ACLARUBICIN HYDROCHLORIDE, ACLARUBICIN HYDROCHLORIDE, PREDONINE, IDARUBICIN. Patient was hospitalized. Patient recovered.

Mylotarg Side Effects Report #5805078-6
Mylotarg side effect was reported by a Physician from JAPAN on July 03, 2008. Male patient, weighting 143.3 lb, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: blood bilirubin increased, neutrophil count decreased, sepsis

, prophylaxis and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: fungaemia, neutrophil count decreased, platelet count decreased, sepsis

, white blood cell count decreased. Mylotarg dosage: unknown. During the same period patient was treated with MAGNESIUM OXIDE HEAVY, OMEPRAL, PANTOSIN, BAKTAR, DIFLUCAN. Patient recovered.

Mylotarg Side Effects Report #4627535-0
Mylotarg side effect was reported by a Consumer or non-health professional from on Mar 22, 2005. Male patient, 86 years of age, weighting 143.1 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: catheter related infection, diarrhoea, haemoglobin decreased, neutropenia, platelet count decreased, staphylococcal bacteraemia, white blood cell count decreased. Mylotarg dosage: 11 MG ^WEEKLY, REPEAT EVERY 28 DAYS^. Patient was hospitalized. Patient recovered.

Mylotarg Side Effects Report #4635718-9
Mylotarg side effect was reported by a Consumer or non-health professional from on Apr 05, 2005. Male patient, 86 years of age, weighting 143.1 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: catheter related infection, diarrhoea, haemoglobin decreased, neutropenia, platelet count decreased, staphylococcal bacteraemia, white blood cell count decreased. Mylotarg dosage: 11 MG 1X PER 1 DAY, INTRAVENOUS. Patient was hospitalized. Patient recovered.

Mylotarg Side Effects Report #5158526-1
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Nov 09, 2006. Female patient, 85 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: febrile neutropenia, gastrointestinal haemorrhage, haematocrit decreased, haematuria, haemoglobin decreased, platelet count decreased, urinary tract infection

, white blood cell count decreased. Mylotarg dosage: 7 MG/M^2 1 PER 1 DAY. During the same period patient was treated with TOWAMIN, CALCIUM CARBONATE, SELBEX, SULFAMETHOXAZOLE, MAGNESIUM OXIDE, MUCOSTA. Patient was hospitalized. Patient died.

Mylotarg Side Effects Report #4802758-6
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Oct 03, 2005. Female patient, 85 years of age, weighting 141.8 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: blood urea increased, cellulitis

, deep vein thrombosis

, disease progression, haemoglobin decreased, white blood cell count decreased. Mylotarg dosage: 15.5 MG OVER 2 HOURS, INTRAVENOUS. During the same period patient was treated with VANCOMYCIN, LEVAQUIN, DIFLUCAN, VALTREX, AMBIEN, TAMOXIFEN CITRATE, SENOKOT. Patient was hospitalized. Patient died on 04/27/2004.

Mylotarg Side Effects Report #4802758-6
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Oct 03, 2005. Female patient, 85 years of age, weighting 141.8 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: blood urea increased, cellulitis

, deep vein thrombosis

, disease progression, haemoglobin decreased, white blood cell count decreased. Mylotarg dosage: 15.5 MG OVER 2 HOURS, INTRAVENOUS. During the same period patient was treated with VANCOMYCIN, LEVAQUIN, DIFLUCAN, VALTREX, AMBIEN, TAMOXIFEN CITRATE, SENOKOT. Patient was hospitalized. Patient died on 04/27/2004.

Mylotarg Side Effects Report #4867685-7
Mylotarg side effect was reported by a Physician from UNITED STATES on Apr 13, 2002. Female patient, 81 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: dehydration, epistaxis, melaena, nausea

, rectal haemorrhage, thrombocytopenia, white blood cell count decreased. Mylotarg dosage: 9 MG/M 2/CYCLE, INTRAVENOUS. Patient was hospitalized. Patient recovered.

Mylotarg Side Effects Report #4869804-5
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Dec 20, 2005. Male patient, 81 years of age, weighting 152.6 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: febrile neutropenia, haematocrit decreased, haemoglobin decreased, white blood cell count decreased. Mylotarg dosage: 18 MG 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with LEVAQUIN, FLOMAX, ACYCLOVIR, FLUCONAZOLE. Patient was hospitalized. Patient recovered.

Mylotarg Side Effects Report #4806045-1
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Oct 07, 2005. Female patient, 77 years of age, weighting 130.7 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: body temperature increased, chills, febrile neutropenia, white blood cell count decreased. Mylotarg dosage: 10 MG 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with CYTARABINE, MITOXANTRONE. Patient was hospitalized. Patient recovered.

Mylotarg Side Effects Report #4867682-1
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on May 11, 1999. Male patient, 77 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: asthenia, granulocytopenia, neutropenia, pyrexia, syncope, white blood cell count decreased. Mylotarg dosage: 9MG/M 2/CYCLE, INTRAVENOUS. Patient was hospitalized. Patient died on 04/01/1998.

Mylotarg Side Effects Report #5041733-6
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on June 16, 2006. Female patient, 77 years of age, weighting 130.7 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: chills, febrile neutropenia, white blood cell count decreased. Mylotarg dosage: 10 MG 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with CYTARABINE, NOVANTRONE. Patient was hospitalized. Patient recovered.

Mylotarg Side Effects Report #4717331-8
Mylotarg side effect was reported by a Health Professional from UNITED STATES on May 24, 2004. Female patient, 76 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: white blood cell count decreased. Mylotarg dosage: 0.9 MG/M^2 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with ALLOPURINOL, ZOLOFT, ZESTRIL, ALLEGRA, MEGACE, BENADRYL, TYLENOL, DULCOLAX. Patient was hospitalized. Patient recovered.

Mylotarg Side Effects Report #4853928-2
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Nov 30, 2005. Male patient, 76 years of age, weighting 175.0 lb, was diagnosed with acute myeloid leukaemia, myelodysplastic syndrome and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: febrile neutropenia, white blood cell count decreased. Mylotarg dosage: A SINGLE 6 MG DOSE, INTRAVENOUS. During the same period patient was treated with ARSENIC TRIOXIDE, ARSENIC TRIOXIDE, ATENOLOL, SYNTHROID, PRILOSEC, PROSCAR, VITAMINS. Patient was hospitalized. Patient recovered.

Mylotarg Side Effects Report #4918248-6
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Feb 06, 2006. Male patient, 76 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: anaemia, c-reactive protein increased, infection

, neutrophil count decreased, platelet count decreased, white blood cell count decreased. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY. During the same period patient was treated with SULFAMETHOXAZOLE, CIPROFLOXACIN HYDROCHLORIDE, FLUCONAZOLE, ROXATIDINE ACETATE. Patient recovered.

Mylotarg Side Effects Report #4924073-2
Mylotarg side effect was reported by a Health Professional from UNITED STATES on Feb 10, 2006. Male patient, 76 years of age, weighting 175.0 lb, was diagnosed with acute myeloid leukaemia, myelodysplastic syndrome and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: febrile neutropenia, white blood cell count decreased. Mylotarg dosage: A SINGLE 6 MG DOSE, INTRAVENOUS. During the same period patient was treated with ARSENIC TRIOXIDE, ARSENIC TRIOXIDE, ARSENIC TRIOXIDE, ARSENIC TRIOXIDE, ATENOLOL, SYNTHROOID, PRILOSEC. Patient was hospitalized. Patient recovered.

Mylotarg Side Effects Report #4998730-6
Mylotarg side effect was reported by a Health Professional from JAPAN on Apr 27, 2006. Male patient, 76 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: anaemia, febrile neutropenia, platelet count decreased, white blood cell count decreased. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY. During the same period patient was treated with BACTAR, CIPROFLOXACIN HYDROCHLORIDE, FLUCONAZOLE, ROXATIDINE ACETATE. Patient recovered.

Mylotarg Side Effects Report #5091364-7
Mylotarg side effect was reported by a Physician from UNITED STATES on Aug 17, 2006. Female patient, 74 years of age, weighting 176.4 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: bacterial infection

, blood culture positive, clostridium difficile toxin test positive, culture stool positive, enterococcal infection, white blood cell count decreased. Mylotarg dosage: 17 MG 1X PER 1 DAY, INTRAVENOUS. Patient was hospitalized. Patient recovered.

Mylotarg Side Effects Report #4977027-4
Mylotarg side effect was reported by a Physician from UNITED STATES on Mar 30, 2006. Male patient, 74 years of age, weighting 168.7 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, disease progression, infection

, infusion related reaction, nausea

, pyrexia, white blood cell count decreased. Mylotarg dosage: 17 MG 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with CIPROFLOXACIN, METOPROLOL, ISOSORBIDE, DIPHENHYDRAMINE, ALLOPURINOL, NEXIUM, ACETAMINOPHEN. Patient was hospitalized. Patient died on 12/30/2002.

Mylotarg Side Effects Report #5150679-4
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Oct 30, 2006. Male patient, 73 years of age, was diagnosed with acute myeloid leukaemia, leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: disease progression, disseminated intravascular coagulation, hypoxia, infection

, interstitial lung disease, weight increased, white blood cell count decreased, white blood cell count increased. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY INTRAVENOUS DRIP. During the same period patient was treated with ORGARAN, FIRSTCIN, FUNGUARD, AMARYL, METFORMIN HYDROCHLORIDE, DIOVAN. Patient died.

Mylotarg Side Effects Report #4952733-6
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on June 14, 2004. Male patient, 72 years of age, weighting 321.9 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, disease progression, haemoglobin decreased, neutrophil count decreased, platelet count decreased, pyrexia, shoulder pain, white blood cell count decreased. Mylotarg dosage: unknown. Patient was hospitalized. Patient died.

Mylotarg Side Effects Report #4911621-1
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 30, 2006. Male patient, 71 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: epididymitis, pyrexia, rash

, scrotal oedema, white blood cell count decreased. Mylotarg dosage: 9 MG/M^2 (17 MG), INTREAVEOUS. During the same period patient was treated with IMIPENEM. Patient was hospitalized. Patient recovered.

Mylotarg Side Effects Report #4911621-1
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 30, 2006. Male patient, 71 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: epididymitis, pyrexia, rash

, scrotal oedema, white blood cell count decreased. Mylotarg dosage: 9 MG/M^2 (17 MG), INTREAVEOUS. During the same period patient was treated with IMIPENEM. Patient was hospitalized. Patient recovered.

Mylotarg Side Effects Report #4952719-1
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on July 29, 2004. Female patient, 68 years of age, weighting 238.2 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: bacteria blood identified, cerebral infarction, infusion related reaction, neutropenia, staphylococcal infection

, thrombocytopenia, white blood cell count decreased. Mylotarg dosage: 19 MG ONE TIME PER ONE DOSE, INTRAVENOUS. During the same period patient was treated with ESTRADERM. Patient was hospitalized. Patient recovered.

Mylotarg Side Effects Report #4553398-8
Mylotarg side effect was reported by a Consumer or non-health professional from on Jan 06, 2005. Male patient, 65 years of age, weighting 166.7 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: blood bilirubin increased, blood chloride increased, blood urea increased, platelet count decreased, white blood cell count decreased. Mylotarg dosage: 18.6 MG 1X PER 1 DAY, INTRAVENOUS. Patient was hospitalized. Patient recovered.

Mylotarg Side Effects Report #4570073-4
Mylotarg side effect was reported by a Consumer or non-health professional from on Jan 17, 2005. Male patient, 65 years of age, weighting 166.7 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, blood bilirubin increased, blood chloride increased, blood urea increased, haemolysis, platelet count decreased, white blood cell count decreased. Mylotarg dosage: 18.6 MG 1 X PER 1 DAY, INTRAVENOUS. Patient recovered.

Mylotarg Side Effects Report #4648955-4
Mylotarg side effect was reported by a Consumer or non-health professional from on Apr 14, 2005. Male patient, 65 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: febrile neutropenia, white blood cell count decreased. Mylotarg dosage: A SINGLE 17.4 MG DOSE, INTRAVENOUS. Patient was hospitalized. Patient recovered.

Mylotarg Side Effects Report #4747096-5
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 09, 2005. Male patient, 65 years of age, weighting 198.0 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: anorexia, confusional state, dysphagia, enterocolitis, platelet count decreased, white blood cell count decreased. Mylotarg dosage: 6 MG/M^2, INTRAVENOUS ; 4.2 MG/M^2, INTRAVENOUS. During the same period patient was treated with CYTARABINE. Patient died on 06/23/2005.

Mylotarg Side Effects Report #4952604-5
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 08, 2006. Male patient, 60 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: bacterial infection

, body temperature increased, catheter site erythema, febrile neutropenia, infusion related reaction, orthostatic hypotension, white blood cell count decreased. Mylotarg dosage: 14.46 MG 1X PER 1 DAY, INTRAVENOUS. Patient was hospitalized. Patient recovered.

Mylotarg Side Effects Report #5217084-3
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Jan 09, 2007. Male patient, 58 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: anaemia, blood bilirubin increased, condition aggravated, pharyngitis, platelet count decreased, pneumonia

, septic shock, white blood cell count decreased. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY. During the same period patient was treated with MAXIPIME, VANCOMYCIN, FUNGUARD, TIENAM, ITRACONAZOLE, OMEGACIN, SULFAMETHOXAZOLE. Patient was hospitalized. Patient recovered.

Mylotarg Side Effects Report #4928865-5
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Feb 15, 2006. Female patient, 58 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: febrile neutropenia, haematocrit decreased, haemoglobin decreased, liver abscess, platelet count decreased, red blood cell count decreased, white blood cell count decreased. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY. During the same period patient was treated with CEFPIROME, MINOPHAGEN C, FUNGUARD, CIPRO, NEUTROGIN. Patient was hospitalized. Patient recovered.

Mylotarg Side Effects Report #4973884-6
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 28, 2006. Male patient, 56 years of age, weighting 233.6 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: neutropenia, pyrexia, white blood cell count decreased. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY, INTRAVENOUS. Patient was hospitalized. Patient recovered.

Mylotarg Side Effects Report #5060481-X
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on July 10, 2006. Female patient, 55 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: disease progression, febrile neutropenia, staphylococcal infection

, white blood cell count decreased. Mylotarg dosage: unknown. During the same period patient was treated with PROVIGIL, GLUCOTROL, TRAMADOL, DIFLUCAN, ACYCLOVIR, TEQUIN, PROTONIX. Patient was hospitalized. Patient recovered.

Mylotarg Side Effects Report #4556863-2
Mylotarg side effect was reported by a Consumer or non-health professional from on Jan 06, 2005. Female patient, 55 years of age, weighting 82.89 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, platelet count decreased, prothrombin time prolonged, white blood cell count decreased. Mylotarg dosage: 11 MG 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with CANCIDAS. Patient was hospitalized. Patient recovered.

Mylotarg Side Effects Report #4570069-2
Mylotarg side effect was reported by a Consumer or non-health professional from on Jan 17, 2005. Female patient, 55 years of age, weighting 82.89 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, platelet count decreased, prothrombin time prolonged, white blood cell count decreased. Mylotarg dosage: 11 MG 1 X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with CANCIDAS. Patient was hospitalized. Patient recovered.

Mylotarg Side Effects Report #4569110-2
Mylotarg side effect was reported by a Consumer or non-health professional from on Jan 27, 2005. Female patient, 55 years of age, weighting 82.89 lb, was diagnosed with acute myeloid leukaemia, pneumonia

and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, platelet count decreased, prothrombin time prolonged, white blood cell count decreased. Mylotarg dosage: 11 MG 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with CANCIDAS. Patient recovered.

Mylotarg Side Effects Report #4688233-0
Mylotarg side effect was reported by a Health Professional from on May 31, 2005. Female patient, 54 years of age, weighting 148.4 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: cholelithiasis, haematocrit decreased, haemoglobin decreased, neutropenia, platelet count decreased, white blood cell count decreased. Mylotarg dosage: 10.26 MG 1X PER 1 DAY, INTRAVENOUS. Patient was hospitalized. Patient recovered.

Mylotarg Side Effects Report #5055471-7
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on June 30, 2006. Female patient, 53 years of age, weighting 194.2 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: candidiasis, dyspnoea, febrile neutropenia, hypoxia, lung neoplasm, white blood cell count decreased. Mylotarg dosage: 11.6 MG 1X PER 1 DAY, INTRAVENOUS. Patient was hospitalized. Patient recovered.

Mylotarg Side Effects Report #4949321-4
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 08, 2006. Male patient, 50 years of age, weighting 165.1 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: asthenia, fatigue, febrile neutropenia, infusion related reaction, pain

, white blood cell count decreased. Mylotarg dosage: 16.4 MG 1X PER 1 DAY, INTRAVENOUS; 17 MG 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with AMPHOTERICIN B, ACETAMINOPHEN. Patient was hospitalized. Patient recovered.

Mylotarg Side Effects Report #5113799-6
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Sept 19, 2006. Male patient, 46 years of age, weighting 182.2 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: bacterial infection

, bronchopulmonary aspergillosis, herpes simplex

, neutropenia, respiratory distress, white blood cell count decreased. Mylotarg dosage: A SINGLE 18.8 MG DOSE, INTRAVENOUS. Patient was hospitalized. Patient died on 01/05/2006.

Mylotarg Side Effects Report #4870089-4
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Dec 20, 2005. Male patient, 46 years of age, weighting 186.7 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: bacterial infection

, body temperature increased, chills, herpes virus infection, malaise, neutropenia, pyrexia, white blood cell count decreased. Mylotarg dosage: A SINGLE 18.8 MG DOSE, INTRAVENOUS. Patient was hospitalized. Patient recovered.

Mylotarg Side Effects Report #4884457-8
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 06, 2006. Male patient, 46 years of age, weighting 182.2 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: herpes simplex

, neutropenia, pneumonia aspergillus, respiratory distress, white blood cell count decreased. Mylotarg dosage: A SINGLE 18.8 MG DOSE, INTRAVENOUS. Patient was hospitalized. Patient died on 01/05/2006.

Mylotarg Side Effects Report #4952641-0
Mylotarg side effect was reported by a Physician from UNITED STATES on July 29, 2004. Male patient, 45 years of age, weighting 151.1 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: nausea

, neutropenia, thrombocytopenia, white blood cell count decreased. Mylotarg dosage: 16 MG 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with ACETAMINOPHEN, DIPHENHYDRAMINE, DILAUDID. Patient was hospitalized. Patient recovered.

Mylotarg Side Effects Report #5013787-4
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on May 17, 2006. Male patient, 37 years of age, weighting 271.8 lb, was diagnosed with acute myeloid leukaemia, fungal infection

and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, febrile neutropenia, malignant neoplasm progression, renal failure, white blood cell count decreased. Mylotarg dosage: 9 MG/M^1 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with AMPHOTERICIN B, DEMEROL, AMILORIDE, ASCORBIC ACID, VITAMINS, NEURONTIN, BENADRYL. Patient was hospitalized. Patient died on 01/29/2003.

Mylotarg Side Effects Report #5215302-9
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Jan 09, 2007. Male patient, 36 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: body temperature increased, neutrophil count decreased, platelet count decreased, white blood cell count decreased. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY. During the same period patient was treated with MORPHINE HYDROCHLORIDE, VOLTAREN, FAMOTIDINE, CONIEL, DIFLUCAN, URSO, POLYMYXIN B SULPHATE. Patient died.

Mylotarg Side Effects Report #4952744-0
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on July 27, 2004. Male patient, child 3 years of age, weighting 35.49 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: anaemia, chills, epistaxis, pyrexia, thrombocytopenia, white blood cell count decreased. Mylotarg dosage: unknown. During the same period patient was treated with SULFATRIM. Patient was hospitalized. Patient recovered.

Mylotarg Side Effects Report #4607040-8
Mylotarg side effect was reported by a Consumer or non-health professional from on Feb 28, 2005. Female patient, 23 years of age, weighting 140.4 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: febrile neutropenia, white blood cell count decreased. Mylotarg dosage: 10.8 MG 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with CYTARABINE. Patient was hospitalized. Patient recovered.

Mylotarg Side Effects Report #5374514-4
Mylotarg side effect was reported by a Physician from JAPAN on June 21, 2007. Female patient, weighting 88.18 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: blast cells present, chills, condition aggravated, febrile neutropenia, hepatitis

, neutrophil count decreased, white blood cell count decreased. Mylotarg dosage: unknown. During the same period patient was treated with DIFLUCAN, BAKTAR, LEVOFLOXACIN. Patient recovered.

Mylotarg Side Effects Report #5388508-6
Mylotarg side effect was reported by a Physician from JAPAN on July 09, 2007. Male patient, weighting 119.0 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acidosis, liver disorder, lymphocyte count decreased, neutrophil count decreased, sinus tachycardia, white blood cell count decreased. Mylotarg dosage: unknown. During the same period patient was treated with OMEGACIN, METHOTREXATE. Patient was hospitalized. Patient recovered.

Mylotarg Side Effects Report #5499630-8
Mylotarg side effect was reported by a Physician from JAPAN on Oct 22, 2007. Female patient, weighting 112.4 lb, was diagnosed with acute myeloid leukaemia, prophylaxis and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: disseminated intravascular coagulation, febrile neutropenia, haemoglobin decreased, neutrophil count decreased, platelet count decreased, pneumonia

, pulmonary haemorrhage, white blood cell count decreased. Mylotarg dosage: unknown. During the same period patient was treated with LASIX, BAKTAR, ALTAT, CIBENOL, ZOLPIDEM TARTRATE, ENTERONON, MAGNESIUM OXIDE. Patient died on 08/21/2007.

Mylotarg Side Effects Report #4907377-9
Mylotarg side effect was reported by a Health Professional from JAPAN on Jan 27, 2006. Male patient was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: fibrin d dimer increased, platelet count decreased, white blood cell count decreased. Mylotarg dosage: 15 MG 1X PER 1 DAY, INTRAVENOUS DRIP. Patient was hospitalized. Patient recovered.

Mylotarg Side Effects Report #4717336-7
Mylotarg side effect was reported by a Health Professional from UNITED STATES on June 14, 2004. Male patient, 73 years of age, weighting 281.2 lb, was diagnosed with acute leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: platelet count decreased, white blood cell count decreased. Mylotarg dosage: 23 MG 1X PER 1 DAY, INTRAVENOUS. Patient recovered.

Mylotarg Side Effects Report #5598146-8
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 17, 2008. Female patient, weighting 198.4 lb, was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, white blood cell count decreased. Mylotarg dosage: 12 MG. During the same period patient was treated with CYTARABINE, DAUNORUBICIN. Patient was hospitalized. Patient recovered.

Mylotarg and white blood cell count decreased

SideEffects101.com

Mylotarg and white blood cell count decreased Patient Reports February 12, 2012

side effects of Mylotarg